Abbvie Inc (ABBV)

NYSE

$253.44

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

Sector:

Industry:

68 analysts

Buy

Target: $266.57 (+5.18%)

Market Cap

$432B

PEG Ratio

0.40

Forward P/E

18.02

P/E Ratio

139.08

Adjust inflation

Log

Valuation

Market Cap$432B

P/E139.08

Forward P/E18.02

PEG0.40

P/S7.15

P/B50.46

Profitability

Total Revenue (TTM)$63B

Gross Profit (TTM)$45B

EBITDA$16B

Profit Margin4.6%

Operating Margin26.6%

EPS$1.76

Financial Health

Free Cash Flow Yield4.62%

Dividend Yield2.65%

Growth & Risk

EPS 5Y CAGR-19.65%

Revenue 5Y CAGR+4.59%

FCF 5Y CAGR+2.35%

Dividends 5Y CAGR+10.77%

Beta (5Y)0.28

Sharpe Ratio1.18